BNP Paribas Asset Management
PRAX icon

BNP Paribas Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

BNP Paribas Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
360
-64
-15% -$20.3K ﹤0.01% 1508
2026
Q1 		$137K Buy
424
+145
+52% +$44.9K ﹤0.01% 1422
2025
Q4 		$82K Buy
279
+116
+71% +$21.6K ﹤0.01% 1527
2025
Q3 		$9K Buy
163
+30
+23% +$1.46K ﹤0.01% 1673
2025
Q2 		$6K Buy
+133
New +$5.07K ﹤0.01% 1954

Other funds holding PRAX

JTL
Jupiter Topco LLC New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BNP Paribas Asset Management's PRAX Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 15% in Q2 2026, selling an estimated $20.3K and leaving 360 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

BNP Paribas Asset Management first reported a position in PRAX in Q2 2025 and has held it in 5 quarters since. The position peaked at $137K in Q1 2026. 280 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • BNP Paribas Asset Management held 360 shares of Praxis Precision Medicines worth $121K as of Q2 2026.
  • BNP Paribas Asset Management sold 64 Praxis Precision Medicines shares in Q2 2026, an estimated $20.3K.
  • Praxis Precision Medicines made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1508 holding.
  • BNP Paribas Asset Management first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Praxis Precision Medicines position peaked at $137K in Q1 2026.
  • 280 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.